Entry |
|
Name |
TGFA-overexpression to PI3K signaling pathway
|
Definition |
TGFA* -> EGFR -> PI3K -> PIP3 -> AKT |
Expanded |
7039v1 -> 1956 -> (5290,5291,5293) -> C05981 -> (207,208,10000) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00048 | Hepatocellular carcinoma |
|
Gene |
7039 | TGFA; transforming growth factor alpha |
1956 | EGFR; epidermal growth factor receptor |
5290 | PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
5291 | PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
5293 | PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
207 | AKT1; AKT serine/threonine kinase 1 |
208 | AKT2; AKT serine/threonine kinase 2 |
10000 | AKT3; AKT serine/threonine kinase 3 |
|
Variant |
7039v1 (TGFA*) TGFA overexpression
|
Metabolite |
C05981 | Phosphatidylinositol-3,4,5-trisphosphate |
|
Reference |
|
Authors |
Yarden Y, Sliwkowski MX. |
Title |
Untangling the ErbB signalling network. |
Journal |
|
Reference |
|
Authors |
Hutchinson RA, Adams RA, McArt DG, Salto-Tellez M, Jasani B, Hamilton PW |
Title |
Epidermal growth factor receptor immunohistochemistry: new opportunities in metastatic colorectal cancer. |
Journal |
|
Reference |
|
Authors |
Whittaker S, Marais R, Zhu AX |
Title |
The role of signaling pathways in the development and treatment of hepatocellular carcinoma. |
Journal |
|
Reference |
|
Authors |
Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. |
Title |
Genomics and signaling pathways in hepatocellular carcinoma. |
Journal |
|
LinkDB |
|